ProShare Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273K | Sell |
|
|||||
|
2025
Q1 | $254K | Sell |
|
|||||
|
2024
Q4 | $460K | Buy |
|
|||||
|
2024
Q3 | $415K | Buy |
|
|||||
|
2024
Q2 | $308K | Sell |
|
|||||
|
2024
Q1 | $469K | Buy |
|
|||||
|
2023
Q4 | $305K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $205K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $263K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $293K | Sell |
|
|||||
|
2021
Q4 | $388K | Buy |
|
|||||
|
2021
Q3 | $318K | Sell |
|
|||||
|
2021
Q2 | $340K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $30K | Buy |
|
|||||
|
2018
Q2 | $30K | Sell |
|
|||||
|
2018
Q1 | $186K | Sell |
|
|||||
|
2017
Q4 | $264K | Buy |
|
|||||
|
2017
Q3 | $231K | Buy |
|
|||||
|
2017
Q2 | $185K | Sell |
|
|||||
|
2017
Q1 | $275K | Sell |
|
|||||
|
2016
Q4 | $291K | Buy |
|
|||||
|
2016
Q3 | $294K | Sell |
|
|||||
|
2016
Q2 | $374K | Buy |
|
|||||
|
2016
Q1 | $322K | Sell |
|
|||||
|
2015
Q4 | $1.47M | Buy |
|
|||||
|
2015
Q3 | $892K | Sell |
|
|||||
|
2015
Q2 | $2.3M | Sell |
|
|||||
|
2015
Q1 | $2.66M | Buy |
|
|||||
|
2014
Q4 | $1.43M | Sell |
|
|||||
|
2014
Q3 | $1.06M | Sell |
|
|||||
|
2014
Q2 | $1.59M | Sell |
|
|||||
|
2014
Q1 | $2.8M | Buy |
|
|||||
|
2013
Q4 | $1.02M | Sell |
|
|||||
|
2013
Q3 | $2.82M | Buy |
|
|||||
|
2013
Q2 | $1.06M | Buy |
|